Funding agency DST

Start date March 27, 2023

End Date None

Duration None

Disease category Cystic fibrosis

Type of study In vitro study

Type of data Quantitative data

Aims of objective • To develop the process chemistry & optimize the process of synthesis for Ivacaftor and Lumacaftorunder patent to make it affordable for Cystic Fibrosis patients in India. • To apply eco-friendly synthetic approaches in the process chemistry. • To characterize the synthesized product using spectral analysis. • To perform profiling for any impurity produced during the synthesis.

Keyword Ivacaftor, CFTR modulator, Lumacaftor, Cystic Fibrosis,

Description None

Total Sanctioned budget None